Aluminium and the risk for alzheimer's disease

Environmetrics

Volumn 6, Issue 3, 1995, Pages 233-275

  McLachlan, D R C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

aluminium; Alzheimer's disease

Indexed keywords

ALUMINIUM; ALZHEIMER'S DISEASE; HEALTH HAZARDS; WATER SUPPLY;

ALUMINIUM; ALUMINIUM CONTAMINATION; ALZHEIMER'S DISEASE; DRINKING WATER; MEDICAL GEOGRAPHY; RISK FACTOR;

CANADA, ONTARIO;

EID: 0028981483     PISSN: 11804009     EISSN: 1099095X     Source Type: Journal    
DOI: 10.1002/env.3170060303     Document Type: Article

References (325)

1. The prevalence and malignancy of Alzheimer disease. A major killer
2. The Canadian study of health and aging: study methods and prevalence of dementia
3. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
4. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
5. Early‐onset Alzheimer's disease caused by mutations at codon 717 of the beta‐amyloid precursor protein gene
6. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β‐amyloid precursor protein gene
7. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N‐terminus of betaamyloid
8. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
9. Genetic evidence for a novel familial Alzheimers disease locus on chromosome 14
10. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage
11. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
12. Association of apolipoprotein E allele epsilon 4 with late‐onset familial and sporadic Alzheimer's disease
13. Alzheimer's disease and possible gene interaction
14. Ueber die Wirkung des aluminium besonderer Berucksichtiqung der durch das aluminum verursachten Lasionen im Centralnervensystem
15. Brain aluminium distribution in Alzheimer's disease and experimental neurofibrillary degeneration
16. Aluminium, neurofibrillary degeneration and Alzheimer disease
17. Alterations in short term retention, conditioned avoidance response acquisition and motivation following aluminium induced neurofibrillary degeneration
18. Aluminium induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention
19. Dementia: Recent observations on Alzheimer's disease and experimental aluminium encephalopathy
20. Neuronal correlates of an encephalopathy induced by aluminum neurofibrillary degeneration
21. Brain destruction alone does not elevate brain aluminium
22. Absence of aluminium in neuritic plaque cores in Alzheimer's disease
23. Microanalysis of senile plaques using nuclear microscopy
24. Aluminum uptake into the rat brain and its relation to Alzheimer's disease
25. A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive x‐ray microprobe and flameless atomic absorption spectrophotometry
26. Laser microprobe analysis of brain aluminum in Alzheimer's disease
27. Laser microprobe mass analyzer (LAMMA) — a new approach to the study of the association of aluminum and neurofibrillary tangle formation
28. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study
29. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease; an X‐ray microanalysis
30. Neuromelanin‐containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease: a LAMMA study
31. Calcium, magnesium and aluminum concentrations in Parkinson's disease
32. Geographical relation between Alzheimer's disease and aluminum in drinking water
33. Aluminum, Alzheimer's disease and drinking water
34. Aluminum in drinking water and risk for diagnoses of presenile Alzheimer's type dementia
35. Dementia, aluminum and fluoride
36. Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA). I. Results from a preliminary investigation
37. Aluminum and dementia
38. Geochemical risk factors for mental functioning, based on the Ontario longitudinal study of aging (LSA) II. The role of pH
39. Acute toxicity of aluminum to fish eliminated in silicon‐rich acid waters
40. Effect of silicon on gastrointestinal absorption of aluminium
41. Bone mass and dementia in hip fracture patients from areas with different aluminum concentrations in water supplies
42. Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water
43. An interaction of β‐amyloid with aluminium in vitro
44. Effect of exposure of miners to aluminium powder
45. Neuropathology and biochemistry of Alzheimer's disease and aluminum encephalopathy
46. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition
47. The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4
48. Biochemistry of Alzheimer's disease amyloid plaques
49. Alzheimer aß amyloid forms an inhibitory neuronal substrate
50. Aluminosilicates and senile plaque formation in Alzheimer's disease
51. Regulation of serine protease activity by aluminum: implications for Alzheimer disease
52. Reversible in vitro growth of Alzheimer disease β‐amyloid plaques by deposition of labeled amyloid peptide
53. Aluminum salts accelerate peroxidation of membrane lipids stimulated by iron salts
54. Aluminum(III) facilitates the oxidation of NADH by the superoxide anion
55. Amyloid β‐peptide is produced by cultured cells during normal metabolism
56. Amyloidogenicity of βA4 and βA4‐bearing amyloid protein precursor fragments by metal‐catalyzed oxidation
57. Aluminum accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure
58. The dialysis encephalopathy syndrome: possible aluminum intoxication
59. Abnormal phosphorylation of the microtubule‐associated protein τ (tau) in Alzheimer cytoskeletal pathology
60. Brain levels of microtubule‐associated protein τ are elevated in Alzheimer's disease: A radioimmuno‐slot‐blot assay for nanograms of the protein
61. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease
62. Alzheimer's disease: X‐ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle‐bearing neurons
63. Aluminum accumulation in neurofibrillary tangle‐bearing neurons of senile dementia, Alzheimer's type: Detection by intraneuronal X‐ray spectrometry studies of unstained tissue sections
64. Aluminum accumulation in tangle‐bearing neruosn of Alzheimer's disease with Balint's syndrome in a long‐term aluminium refiner
65. Imaging of calcium and aluminum in neurofibrillary tangle‐bearing neurons in parkinsonism‐dementia of Guam
66. X‐ray probe microanalysis of Alzheimer disease soluble and insoluble paired helical filaments
67. A molecular mechanism for the induction of neurofilament bundling by aluminum ions
68. A molecular mechanism of aluminum neurotoxicity
69. Aluminum‐induced nonenzymatic phospho‐incorporation into human tau and other proteins
70. Aggregation of tau protein by aluminum
71. A preparation of Alzheimer paired helical filaments that displays distinct γ proteins by polyacrylamide gel electrophoresis
72. Effects of aluminum on tau proteins in human neuroblastoma cells
73. Human neuroblastoma cells treated with aluminum express and epitope associated with Alzheimer's disease neurofibrillary tangles
74. Accumulation of amyloid protein in damaged neuronal process and microglia following intracerebral administration of aluminum salts
75. Alzheimer's‐disease‐like changes in tau protein processing: Association with aluminium accumulation in brains of renal dialysis patients
76. Senile plaques and tangles in dialysis dementia
77. Alzheimer‐like paired helical filaments and antiparallel dimers formed from microtubule‐associated protein tau in vitro
78. Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease
79. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy
80. Nuclear compartmentalization of aluminum in Alzheimer's disease (AD
81. Characterization of messenger RNA from the cerebral cortex of control and Alzheimer affected brain
82. Selective messenger RNA reduction in Alzheimer's disease
83. Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex
84. Chromatin structure and gene expression in Alzheimer's disease (AD
85. Localization and quantitation of 68kDa neurofilament and superoxide dismutase‐1 mRNA in Alzheimer brains
86. Blockade of neuronal brain RNA initiation sites by aluminum: a primary molecular mechanism of aluminum‐induced neurofibrillary changes
87. Effects of aluminum and other cations on the structure of brain and liver chromatin
88. Aluminum neurotoxicity — altered expression of cytoskeletal genes
89. Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum
90. Effect of Desferrioxamine on the clinical progress of Alzheimer disease
91. Guam amyotrophic lateral sclerosis‐parkinsonism‐dementia linked to a plant excitant neurotoxin
92. The pathogenesis of amyotrophic lateral sclerosis
93. Epidemiologic surveillance of amyotrophic lateral sclerosis and parkinsonism‐dementia in the Commonwealth of the Northern Marina Islands
94. Degenerative changes in the central nervous system of Japanese monkeys induced by oral administration of aluminum salt
95. Low‐calcium, high‐aluminum diet‐induced motor neuron pathology in cynomolgus monkeys
96. Aluminum induced chronic myelopathy in rabbits
97. Copper/zinc superoxide dismutase mRND levels are increased in sporadic amyotrophic lateral sclerosis motorneurons
98. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
99. The high aluminum deposition in the central nervous system of patients with amyotrophic lateral sclerosis from the Kii peninsula, Japan: two case reports
100. New evidence for an active role of aluminum in Alzheimer's disease
101. An introduction to the free radical hypothesis in Parkinson's disease
102. Isoforms of ferritin have a specific cellular distribution in the brain
103. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis
104. Dialysis encephalopathy syndrome
105. The history of aluminum related disease
106. Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients
107. Aluminum transfer during hemodialysis
108. Disturbance of cerebral function by aluminum in haemodialysis patients without overt aluminum toxicity
109. Detection of subtle aluminum‐related renal osteodystrophy
110. Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis
111. Dialysis‐associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis
112. Suboptimal dietary zinc intake increases aluminum accumulation into the rat brain
113. Aluminum concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide
114. Effect of citric acid and maltol on the accumulation of aluminium in rat brain and bone
115. Ranitidine suppresses aluminum absorption in man
116. Genetic influences on tissue deposition of aluminum in mice
117. Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and Alzheimer's disease
118. Raised serum aluminum concentration in Alzheimer's disease
119. Serum aluminum in senile dementia of Alzheimer's type and in multi‐infarct dementia
120. Aluminosilicates and Alzheimer's disease [C
121. Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate
122. Case of aluminium poisoning
123. Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust
124. An evaluation of the combined action of certain physical and chemical harmful factors on the nervous system
125. Risk factors and clinical findings in metallurgists in the aluminium production
126. Protroom palsy?
127. The application of Alzheimer's disease scale for workers professionally exposed to aluminium
128. Significance of neuropsychological testing in circumstances of occupational exposure to aluminium
129. Neurophysiological findings in workers occupationally exposed to aluminium
130. Summary of symposium on toxicology of copper and aluminum
131. Blood and urine concentrations of aluminum among workers exposed to aluminum flake powders
132. Neuropsychiatric symptoms among welders exposed to neurotoxic metals
133. Mental abilities of workers exposed to aluminum
134. Neurologic syndrome in 25 workers from an aluminum smelting plant
135. Molecular interactions of aluminum with DNA
136. Interactions of aluminum species with deoxyribonucleic acid
137. Polynucleotide cross‐linking by aluminum
138. Alterations in human linker histone — DNA binding in the presence of aluminum salts in vitro and in Alzheimer's disease
139. Linker histone — DNA complexes; enhanced stability in the presence of aluminum lactate and implications for Alzheimer's disease
140. Affects of aluminum salts on cultured neuroblastoma cells
141. Aluminum in human brain disease
142. Aluminum inhibition of ADP‐ribosylation in vivo and in vitro.
143. Functional consequences of chromatin bound aluminum in cultured human cells
144. Altered steroid induced puffing by chromatin bound aluminum in a polythene chromosome of the black fly simulium vittatum
145. Inhibition of corticosterone binding in vitro, in rabbit hippocampus by chromatin bound aluminum
146. Total and poly(A) RNA yields during an aluminum encephalopathy in rabbit brains
147. Aluminum neurotoxicity: altered expression of cytoskeletal genes
148. Inhibition of cell division — a critical experimental analysis
149. DNA synthesis in aluminum treated roots of barley
150. Repressed template activity of chromatin of pea roots treated by aluminum
151. Development alterations in offspring of female rats orally intoxicated by aluminum lactate at different gestation periods
152. ‐ with nucleotide and DNA binding of rat histone H1 in vitro. Implications for the pathogenesis of Alzheimer's disease
153. Nucleoside triphosphate binding and hydrolysis by histone H1
154. 32‐P postlabelling detection of aromatic DNA adducts in peripheral blood lymphocytes from aluminum production plant workers
155. A1‐ATP as an intracellular carrier of A1(III) ion
156. Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies
157. Calmodulin dependent formation of membrane potential in barley root plasma membrane vesicles — a biochemical model of aluminum toxicity inplants
158. The effect of aluminum (A1) loading on specific tissue calcium (Ca) and magnesium (Mg) concentrations in normal rats
159. Cellular mechanisms of aluminum toxicity
160. The effect of aluminum on the uptake and incorporation of phosphate by excised sanfoin roots
161. The physiology of metal toxicity in plants
162. Studies of aluminum interaction with enzymes and proteins — the inhibition of hexokinase
163. NMR and infrared spectroscopic investigations of the A1 (III), Ga (III), and Be (II) complexes of ATP
164. Proton‐dependent inhibition of yeast and brain hexokinase by aluminum in ATP preparations
165. Multinuclear NMR studies on A1 (III) complexes of ATP and related compounds
166. Aluminum‐27 NMR study of A1 (III) interactions with carboxylate ligands
167. Inhibition of brain glycolysis by aluminum
168. Aluminum — a requirement for activation of the regulatory component of adenylate cyclase by fluoride
169. The dual effects of aluminum as activater and inhibitor of adenylate cyclase in the liver fluke
170. Cytochemical study on the effect of aluminum on neuronal Golgi apparatus and lysosomes
171. Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on thermodialysis
172. Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic colonergic markers in rat brain in vivo
173. Affects of long term intake of low levels of aluminum on some enzyme activities and ferritin
174. Ferritin: Isolation of aluminum‐ferritin complex from brain
175. Relationship between hepatic peroxisome proliferation and 8‐hydroxydeoxyguanosine formation in liver DNA of rats following long‐term exposure to three peroxisome proliferators; di (2‐ethylhexyl) phthalate, aluminum clofibrate and simfibrate
176. Mechanism of aluminum‐induced inhibition of hepatic glycolysis‐inactivation of phosphofructokinase
177. Examination of elongation factor Tu for aluminum fluoride binding sites using fluorescence and 19F‐NMR methodologies
178. Inhibition of protein kinase‐C activation by low concentrations of aluminium
179. Inhibition of proton‐translocating ATPases of Streptococcus mutans and Lactobacillus casei by fluoride and aluminum
180. Ultrastructural localization of aluminum in liver of aluminum maltol‐treated rabbits by laser microprobe mass analysis
181. Effect of aluminum on rat liver and kidney lysosomes
182. Morphologic and ultrastructural effects of Maalox TC on human gastric and duodenal mucosa
183. Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum
184. A13+ versus Ca2+ ion binding to methionine and tyrosine spin‐labeled bovine brain calmodulin
185. Regulatory role for GTP‐binding proteins in endocytosis
186. Aluminum toxicity and binding to
187. Aluminum hydroxide granulomas: light and electron microscopic studies and X‐ray microanalysis
188. Experimental production of neuro‐fibrillary degeneration 1: Light microscopic observations
189. Experimental production of neurofibrillary degeneration 2: Electromicroscopy, microscopy, phosphatase, histochemistry and electron probe analysis
190. Immunochemical cross‐reactivity of normal neuro‐ fibrils and aluminum‐induced neurofibrillary tangles — immunofluorescence study and antineural filament serum
191. Biochemical and immunological characterization of neurofilaments in experimental neurofibrillary degeneration induced by aluminum
192. An immunocytal chemical comparison of cytoskeletal proteins in aluminum‐induced and Alzheimer‐type neurofibrillary tangles
193. The rabbit retina: a long term model system for aluminum induced neurofibrillary degeneration
194. Aluminum effect on slow transport — A novel impairment of neurofilament transport
195. Axonal transport of cytoskeletal proteins in aluminum toxicity — aluminum toxicity in axonal transport
196. The relaxing effect of aluminum and lanthanum of rat and human gastric smooth muscle in vitro
197. Phosphorylation of rat brain cytoskeletal proteins is increased after orally administered aluminum
198. Oral aluminum alters in vitro protein phosphorylation and kinase activities in rat brain
199. Promotion of tubulin assembly by aluminum ion in vitro
200. Aluminum in biological systems
201. Neuronal cytoskeletal lesions induced in the CNS by intraventribular and intravenous aluminum maltol in rabbits
202. Effect of aluminum and other multivalent cations on neurofilaments in vitro: an electron microscopic study
203. Aluminum inhibits calpain‐mediated proteolysis and induces human neurofilament proteins to form protease‐resistant high molecular weight complexes
204. Immunocytochemical studies of the neurofilament antigens in the neurofibrillary pathology induced by aluminum
205. Aluminum alters the electrophoretic properties of neurofilament proteins: role of phosphorylation state
206. Aluminum induced cytoskeletal abnormalities in PC12 cells
207. Chronic aluminum induced motor neuron degeneration: clinical, neuropathological and molecular biological aspects
208. Neuron‐specific thresholds of aluminum toxicity in vitro. A comparative analysis of dissociated fetal rabbit hippocampal and motor neuron‐enriched cultures
209. Potentiation in the neurotoxic induction of experimental chronic neurodegenerative disorders: N‐butyl benzenesulfonamide and aluminum chloride
210. Characterization of intracyoplamic neurofilament accumulation in hamster brain caused by Alzheimer buffy coat inoculation: comparison with experimental neurofibrillary changes produced by aluminum intoxication
211. Immunohistochemical study of microtubule‐associated protein 2 and ubiquitin in chronically aluminum intoxicated rabbit brain
212. The effect of aluminum 3+ on the physical properties of membranes
213. Modulation of phosphoinositide hydrolysis by NaF and aluminum in rat cortical slices
214. 3+ induce phase separation, aggregation and dye release in phosphatidylserine‐containing lipid vesicles
215. Neurotoxic cations induce membrane rigidification and membrane fusion at micromolar concentrations
216. The effect of cadium, manganese and aluminum on sodium‐potassium‐activated and magnesium‐activated adenosine triphosphate activity and choline uptake in rat brain synaptosomes
217. Effect of aluminum on lipid peroxidation in rats
218. Aluminum increases permeability of the blood‐brain barrier to labelled DSIP and β‐endorphin — possible implications for senile and dialysis dementia
219. Aluminum alters the permeability of the blood‐brain barrier to some non‐peptides
220. The aluminum induced increase in blood‐brain barrier permeability to DISP occurs throughout the brain and is independent of phosphorous and acetylcholinesterase levels
221. Differential effect of aluminum on the blood‐brain barrier, transport of peptides, technetium and albumin
222. The role of speciation in the effects of aluminum (III) on the stability of cell membranes and on the activity of selected enzymes
223. A mechanism for acute aluminum toxicity in fish
224. Aluminum intoxication
225. Measurement of lipid peroxidation products in rabbit brain and organs (response to aluminum exposure
226. Modulatory effects of aluminum, calcium, lithium, magnesium, and zinc ions on [3H]MK‐801 binding in human cerebral cortex
227. Effects of aluminum on electrical and mechanical properties of frog atrial muscle
228. Aluminum determination in the skin of patients with and without end‐stage renal failure
229. Purification of an AlF4‐ and G‐protein beta gamma‐subunit‐regulated phospholipase C‐activating protein
230. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminum on platelet and erythrocyte membranes
231. Synaptic density in chronic animals with experimental neurofibrillary changes
232. Selective inhibition of L‐glutamate and gammaaminobutyrate transporter nerve endings, particles by aluminum, manganese and cadmium chloride
233. High affinity uptake of GABA and glycine by rabbits with aluminum‐induced neurofibrillary degeneration
234. 3+ on rat brain synaptosomal uptake of noradrenalin and seratonin
235. Aluminum neurotoxicity: an experimental perspective
236. Aluminum inhibition of human serum cholinesterase
237. Noncompetitive inhibition of bi‐ aluminum, scandium and yttrium of acetylcholinesterase from
238. Aluminum induced encephalopathy in the rat
239. The influence of ingested aluminum upon norepinephrine and dopamine levels in the rat brain
240. Activity of the enzymes dopamine‐beta‐hydroxylase and phenylethanolamine‐N‐methyltransferase in discreet brain regions of the copper‐zing deficient rat following aluminum ingestion
241. Cholinergic enzymes in neurofibrillary degeneration produced by aluminum
242. Biochemical studies on rabbits with aluminum‐induced neurofilament accumulations
243. Central cholinergic activity in aluminum‐induced neurofibrillary degeneration
244. Aluminum inhibits the fast phase of voltage‐dependent calcium influxes into synaptosomes
245. Desphosphorylation of y factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum
246. Effects of aluminum salts on synaptosomal enzymes: an in vitro kinetic study
247. Aluminum chloride stimulates NaCl‐dependent release of taurine and y‐aminobutyric acid in rat cortical astrocytes
248. The effect of aluminum on muscarinic receptors in isolated cerebral microvessels
249. Control of [3H] ouabain binding to cerebromicrovascular (Na+ K+)‐ATPase by metal ions and proteins
250. 3+ on cholinesterase and acetylcholinesterase activity
251. Plasma aluminum is bound to transferrin
252. Transferrin‐gallium binding in Alzheimer's disease
253. Iron uptake in aluminum overload: in vivo and in vitro studies
254. The effect of exposure to aluminum on concentrations of essential metals in serum of foundry workers
255. 3 dust
256. Case management of the anemic patient epoetin alfa, focus on aluminum management
257. Aluminum mobilization by desferrioxamine by microdialysis of the blood, liver and brain
258. The aluminum content of parental solutions: current status
259. Role of aluminum in skin reactions after diphtheria‐tetanus‐pertussis poliomyelitis vaccination: an experimental study in rabbits
260. Aluminum mobilization following renal transplantation and the possible effect on susceptibility to bacterial sepsis
261. The role of transferrin and citrate in cellular uptake of aluminum
262. The effect of aluminum on the stromal cells (in vitro) on bone marrow in rats
263. Aluminum maltol‐induced neurocytoskeletal changes in fetal rabbit midbrain in matrix culture
264. Hematological changes after long‐term aluminum administration to normal adult rabbits
265. Intestinal absorption of aluminum
266. Chromatographic resolution of aluminum binding components in human serum
267. Defective gallium‐transferrin binding Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain
268. Comparative binding study of aluminum and chromium to human transferrin. Effect of iron
269. Serum aluminum in senile dementia of Alzheimer's type and in multi‐infarct dementia
270. Bone aluminum and histomorphometric features of renal osteodystrophy
271. Solitary, spontaneous cervical and large bone fractures in aluminum osteodystrophy
272. Low dose desferrioxamine test for the diagnosis of aluminum‐related bone disease in patients on regular haemodialysis
273. Successful high‐dose calcium treatment of aluminum‐induced metabolic bone disease in long term parenteral nutrition
274. Aluminum alters calcium influx and efflux from bone in vitro
275. Sequential serum aluminum and urine aluminum: creatinine ratio and tissue aluminum loading in infants with fractures/rickets
276. Effects of etidronate‐mediated suppression of bone remodelling on aluminum induced denovo bone formation
277. Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy
278. Developmental toxicity evaluation of oral aluminum in rats: influence of citrate
279. Some effects of dietary aluminum and silicon on broiler chickens
280. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus‐dependent model of uremic osteomalacia in rats
281. Effect of aluminum on osteocalcin production in the rat
282. Learning deficit in immature rabbits with aluminum‐induced neurofibrillary degeneration
283. Repeated systemic aluminum exposure effects on classical conditioning of the rabbit
284. Comparative toxicity of intracerebroventricular and subcutaneous aluminum in rabbit
285. Aluminum induced osteomalacia and encephalopathy — an abberation of tubulin assembly into microtubules by aluminum?
286. Effects of combined exposure to aluminum and ethanol on aluminum body burden and some neuronal, hepatic and hematopoietic biochemical variables in the rat
287. Effects of dietary aluminum excess and manganese deficiency on neurobehavioral endpoints in adult mice
288. Aluminum in the organs and diet of ageing C57BL/6J mice
289. The effect of aluminum on conditioned avoidance response (CAR) in mice
290. Aluminum accumulation and neurotoxicity in Swiss‐Webster mice after chronic dietary exposure to aluminum and citrate
291. Disrupted retention of the classically conditioned nictitating membrane response in rabbits with aluminum‐induced neurofibrillary degeneration
292. Aluminum‐induced neurofibrillary degeneration disrupts acquisition of the rabbit's classically conditioned nictating membrane response
293. Proteolytic activity in brains of rabbits treated with aluminum
294. Evaluation on magnesium, calcium and aluminum metabolism in rats and monkeys maintained on calcium deficient diets
295. Mise en evidence de l'aluminum dans les plaques de la maladie d'Alzheimer: Etude a la microsonde de Castaing
296. Aluminum levels in brain in Alzheimer's disease
297. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy
298. Neuronal origin of cerebral amyloid; neurofibrillary tangles contain the same protein as the amyloid plaque cores and blood vessels
299. Aluminum neurotoxicity in rat brain
300. Brain aluminum in Alzheimer's disease using an improved GFAAS method
301. Hippocampal tin, aluminum and zinc in Alzheimer's disease
302. High serum aluminum levels and acute reversible encephalopathy in a 4 year old boy with acute renal failure
303. Neurocognitive effects of aluminum
304. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and parkinsonism dementia of Guam
305. Aluminum deposition in the central nervous system of patients with amyotrophic lateral sclerosis from the Kii Peninsula of Japan